AN2 Therapeutics to Participate in Citizens JMP Life Sciences Conference

MENLO PARK, Calif. --(BUSINESS WIRE)--Apr. 30, 2025-- AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom , Co-Founder, Chairman,

Full article
investor.an2therapeutics.com
2025-04-30 15:04:49 ET
ANTX Stock Price Update
IndicatorPrice-beforePrice-afterChange
sameday$1.22$1.24+1.64%
1 days later$1.24$1.24+0.00%
2 days later$1.24$1.22-1.61%
3 days later$1.22$1.2-1.64%
Stocklight
Get real-time news alerts, gain an edge.